Home/Filings/4/0000891293-16-000163
4//SEC Filing

CTI BIOPHARMA CORP 4

Accession 0000891293-16-000163

CIK 0000891293operating

Filed

May 19, 8:00 PM ET

Accepted

May 20, 4:58 PM ET

Size

5.6 KB

Accession

0000891293-16-000163

Insider Transaction Report

Form 4
Period: 2016-05-18
Bianco James A.
DirectorCEO
Transactions
  • Award

    Employee Stock Opyion (Right to Buy)

    2016-05-18+600,000600,000 total
    Exercise: $0.45Exp: 2026-05-18Common Stock (600,000 underlying)
Footnotes (1)
  • [F1]The option vests 12.5% beginning on July 7, 2016 and vests an additional 12.5% every 6 months thereafter, with the final vesting on January 7, 2020, in each case subject to the reporting person's continued employment or service with the issuer through the applicable vesting date. The option can only be exercised if CTI's stock is trading at or above $1.20.

Issuer

CTI BIOPHARMA CORP

CIK 0000891293

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000891293

Filing Metadata

Form type
4
Filed
May 19, 8:00 PM ET
Accepted
May 20, 4:58 PM ET
Size
5.6 KB